An endoscopic approach to metallic foreign bodies of the nose and paranasal sinuses.

R. Mladina,J. Hat,I. Klapan,B. Heinzel

DOI: https://doi.org/10.1016/0196-0709(95)90158-2

IF: 2.873

1995-07-01

American Journal of Otolaryngology

Abstract:

What problem does this paper attempt to address?

Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight

Shaukat Ali,Maryam Zulfiqar,Muhammad Summer,Mahnoor Arshad,Shehzeen Noor,Laiba Nazakat,Abdullah Javed

DOI: https://doi.org/10.1007/s11033-024-09814-w

2024-08-12

Abstract:Cardiovascular disease (CVD) is a common cardiac disorder that leads to heart attacks, strokes, and heart failure. It is primarily characterized by conditions that impact the heart and blood arteries, including peripheral artery disease, arrhythmias, atherosclerosis, myocardial ischemia, congenital heart abnormalities, heart failure, rheumatic heart disease, hypertension, and cardiomyopathies. These conditions are mainly effect the heart and blood vessels, causing blockages or weakened pumping, due to severe hereditary and environmental factors. The frequency of CVD is rising significantly as life expectancy increases. Despite this, no effective treatment or management for its symptoms has been found. One of the most difficult obstacles to overcome, is finding a suitable animal model for drug screening and drug development. Although rodents, mice, swine, and mammals serve as the basis for most animal models of cardiovascular disease, no model accurately captures the epidemiology of the condition. Zebrafish (Danio rerio) have drawn the interest of the international scientific community due to certain shortcomings of the previously discussed animal models because they are smaller, less costly, and have an incredibly high rate of reproduction. This review article emphasizes the significance of using zebrafish as an animal model to investigate the possible facets of cardiovascular disease. Moreover, the ultimate purpose of this review article is to establish the advantages of employing zebrafish over other animal models and to investigate the boundaries of using zebrafish to study human disease. Furthermore, the mechanisms of cardiovascular diseases induction in zebrafish were covered to improve understanding for readers. Finally, the analysis of cardiotoxicity using Zebra fish model, is also explained. In order to stop the health index from deteriorating, the current study also covers some innovative, effective, and relatively safer treatments for treatment and management of cardiotoxicity.
Modeling cardiovascular disease in the zebrafish

Timothy J A Chico,Philip W Ingham,David C Crossman

DOI: https://doi.org/10.1016/j.tcm.2008.04.002

Abstract:The zebrafish possesses a host of advantages that have established it as an excellent model of vertebrate development. These include ease of genetic manipulation and transgenesis, optical clarity, and small size and cost. Biomedical researchers are increasingly exploiting these advantages to model human disease mechanisms. Here we review the use of the zebrafish for cardiovascular research. We summarize previous studies with the use of this organism to model such processes as thrombosis, collateral vessel development, inflammation, cardiomyopathy, and cardiac regeneration, evaluate its promise for novel drug discovery, and consider where the zebrafish fits into the framework of existing cardiovascular models.
Sequential urinary Nτ‐methylhistidine to creatinine ratios in premature infants

Judith L Burgoyne,A. Fitzgerald,G. Dahlenburg,R. Haslam,F. Tomas,F. Ballard

DOI: https://doi.org/10.1002/mus.880090104

1986-01-01

Abstract:The present study was undertaken to establish normal values of the Nτ‐methylhistidine to creatinine excretion ratio in very premature infants, to observe changes with postnatal age, and to determine whether or not reliable data on this index of myofibrillar protein breakdown could be obtained from untimed urine samples without recourse to the 24‐ hour collections used previously. The normal range (95% confidence limits) of the molar excretion ratio for unstressed infants was established to be between 0.0248 and 0.0440. Narrower limits of variability occurred when nutrient intake was controlled at a satisfactory level or when comparisons were between sequential urine samples from single infants. No diurnal changes could be detected. We conclude that analyses of Nτ‐methylhistidine and creatinine on spot urine samples permit the calculation of an excretion ratio that is reproducible both within and between individual infants and that should be useful in assessing changes in myofibrillar protein breakdown caused by differences in clinical, pharmacologic, or nutritional status.
Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

Ramcharan Singh Angom,Naga Malleswara Rao Nakka

DOI: https://doi.org/10.3390/biomedicines12030693

IF: 4.757

2024-03-20

Biomedicines

Abstract:The zebrafish (Danio rerio) has emerged as an appreciated and versatile model organism for studying cardiovascular and metabolic diseases, offering unique advantages for both basic research and drug discovery. The genetic conservation between zebrafish and humans and their high fecundity and transparent embryos allow for efficient large-scale genetic and drug-oriented screening studies. Zebrafish possess a simplified cardiovascular system that shares similarities with mammals, making them particularly suitable for modeling various aspects of heart development, function, and disease. The transparency of zebrafish embryos enables the real-time visualization of cardiovascular dynamics, offering insights into early embryonic events and facilitating the study of heart-related anomalies. In metabolic research, zebrafish provide a cost-effective platform for modeling obesity, type 2 diabetes, hyperlipidemia, and other metabolic disorders. Their high reproductive rate allows for the generation of large cohorts for robust statistical analyses, while advanced genetic tools, such as CRISPR/Cas9, enable precise gene editing with which to model specific genetic mutations associated with human diseases. Zebrafish metabolic models have been instrumental in elucidating the molecular mechanisms underlying metabolic diseases, studying the effects of environmental factors, and identifying potential therapeutic targets. Additionally, the permeability of zebrafish embryos to small molecules facilitates drug discovery and screening, offering a rapid and economical approach to identifying compounds with therapeutic potential. In conclusion, zebrafish cardiovascular and metabolic disease models continue to contribute significantly to our perception of disease pathogenesis, providing a platform for translational research and developing novel therapeutic interventions. The versatility, scalability, and genetic manipulability of zebrafish position them as an invaluable asset in unraveling the complexities of cardiovascular and metabolic diseases. This review presents an overview of the zebrafish model's key features and contributions to investigating cardiovascular and metabolic disorders. We discuss the benefits and drawbacks of using zebrafish models to study human disease and the critical findings revealed by the progress in this endeavor to date.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Zebrafish Heart Failure Models

Suneeta Narumanchi,Hong Wang,Sanni Perttunen,Ilkka Tikkanen,Päivi Lakkisto,Jere Paavola

DOI: https://doi.org/10.3389/fcell.2021.662583

2021-05-20

Abstract:Heart failure causes significant morbidity and mortality worldwide. The understanding of heart failure pathomechanisms and options for treatment remain incomplete. Zebrafish has proven useful for modeling human heart diseases due to similarity of zebrafish and mammalian hearts, fast easily tractable development, and readily available genetic methods. Embryonic cardiac development is rapid and cardiac function is easy to observe and quantify. Reverse genetics, by using morpholinos and CRISPR-Cas9 to modulate gene function, make zebrafish a primary animal model for in vivo studies of candidate genes. Zebrafish are able to effectively regenerate their hearts following injury. However, less attention has been given to using zebrafish models to increase understanding of heart failure and cardiac remodeling, including cardiac hypertrophy and hyperplasia. Here we discuss using zebrafish to study heart failure and cardiac remodeling, and review zebrafish genetic, drug-induced and other heart failure models, discussing the advantages and weaknesses of using zebrafish to model human heart disease. Using zebrafish models will lead to insights on the pathomechanisms of heart failure, with the aim to ultimately provide novel therapies for the prevention and treatment of heart failure.
Advances in Cardiac Development and Regeneration Using Zebrafish as a Model System for High-Throughput Research

Nicholas Francoeur,Rwik Sen

DOI: https://doi.org/10.3390/jdb9040040

2021-09-25

Journal of Developmental Biology

Abstract:Heart disease is the leading cause of death in the United States and worldwide. Understanding the molecular mechanisms of cardiac development and regeneration will improve diagnostic and therapeutic interventions against heart disease. In this direction, zebrafish is an excellent model because several processes of zebrafish heart development are largely conserved in humans, and zebrafish has several advantages as a model organism. Zebrafish transcriptomic profiles undergo alterations during different stages of cardiac development and regeneration which are revealed by RNA-sequencing. ChIP-sequencing has detected genome-wide occupancy of histone post-translational modifications that epigenetically regulate gene expression and identified a locus with enhancer-like characteristics. ATAC-sequencing has identified active enhancers in cardiac progenitor cells during early developmental stages which overlap with occupancy of histone modifications of active transcription as determined by ChIP-sequencing. CRISPR-mediated editing of the zebrafish genome shows how chromatin modifiers and DNA-binding proteins regulate heart development, in association with crucial signaling pathways. Hence, more studies in this direction are essential to improve human health because they answer fundamental questions on cardiac development and regeneration, their differences, and why zebrafish hearts regenerate upon injury, unlike humans. This review focuses on some of the latest studies using state-of-the-art technology enabled by the elegant yet simple zebrafish.
Zebrafish Congenital Heart Disease Models: Opportunities and Challenges

Dixuan Yang,Zhenjie Jian,Changfa Tang,Zhanglin Chen,Zuoqiong Zhou,Lan Zheng,Xiyang Peng

DOI: https://doi.org/10.3390/ijms25115943

2024-05-29

Abstract:Congenital heart defects (CHDs) are common human birth defects. Genetic mutations potentially cause the exhibition of various pathological phenotypes associated with CHDs, occurring alone or as part of certain syndromes. Zebrafish, a model organism with a strong molecular conservation similar to humans, is commonly used in studies on cardiovascular diseases owing to its advantageous features, such as a similarity to human electrophysiology, transparent embryos and larvae for observation, and suitability for forward and reverse genetics technology, to create various economical and easily controlled zebrafish CHD models. In this review, we outline the pros and cons of zebrafish CHD models created by genetic mutations associated with single defects and syndromes and the underlying pathogenic mechanism of CHDs discovered in these models. The challenges of zebrafish CHD models generated through gene editing are also discussed, since the cardiac phenotypes resulting from a single-candidate pathological gene mutation in zebrafish might not mirror the corresponding human phenotypes. The comprehensive review of these zebrafish CHD models will facilitate the understanding of the pathogenic mechanisms of CHDs and offer new opportunities for their treatments and intervention strategies.
Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity

Sarah Lane,Luis Alberto More,Aarti Asnani

DOI: https://doi.org/10.3390/jcdd8020008

2021-01-22

Abstract:Purpose of review: Both traditional and novel cancer therapies can cause cardiovascular toxicity in patients. In vivo models integrating both cardiovascular and cancer phenotypes allow for the study of on- and off-target mechanisms of toxicity arising from these agents. The zebrafish is the optimal whole organism model to screen for cardiotoxicity in a high throughput manner, while simultaneously assessing the role of cardiotoxicity pathways on the cancer therapy's antitumor effect. Here we highlight established zebrafish models of human cardiovascular disease and cancer, the unique advantages of zebrafish to study mechanisms of cancer therapy-associated cardiovascular toxicity, and finally, important limitations to consider when using the zebrafish to study toxicity. Recent findings: Cancer therapy-associated cardiovascular toxicities range from cardiomyopathy with traditional agents to arrhythmias and thrombotic complications associated with newer targeted therapies. The zebrafish can be used to identify novel therapeutic strategies that selectively protect the heart from cancer therapy without affecting antitumor activity. Advances in genome editing technology have enabled the creation of several transgenic zebrafish lines valuable to the study of cardiovascular and cancer pathophysiology. Summary: The high degree of genetic conservation between zebrafish and humans, as well as the ability to recapitulate cardiotoxic phenotypes observed in patients with cancer, make the zebrafish an effective model to study cancer therapy-associated cardiovascular toxicity. Though this model provides several key benefits over existing in vitro and in vivo models, limitations of the zebrafish model include the early developmental stage required for most high-throughput applications.
Insulin Resistance Type A syndrome in a 12-year-old Girl

N. Yokomori,M. Tawata,K. Aida,Zentoshi Abe,Y. Hori,T. Onaya

Abstract:Anobesel2-year-oldgirlwithacanthosisnigricanswasreferredtothehospitalbecause of hyperinsulinemia. She was 156 cm tall and her body weight was 67.5 kg. Physical examination revealed that she had acanthosis Rigricans in the neck, axillary and inguinal regions. She also had hirsutism over the extremities. Endecrlnological data showed mild elevatioRs of plasma luteinizing hormone, testosterene and androstenedione and urinary testosteroRe. A significant reduction of i25I-iRsulin binding to her red blood ce}}s was observed. Serum anti-insulin antibodies or anti-insulin receptor antibodies were not detected. The clinical and laboratory data sugges{ed that this patient had a syndrome known as Type A insulin resistance.
Zebrafish as a Vertebrate Model System to Evaluate Effects of Environmental Toxicants on Cardiac Development and Function

Swapnalee Sarmah,James Marrs

DOI: https://doi.org/10.3390/ijms17122123

IF: 5.6

2016-12-16

International Journal of Molecular Sciences

Abstract:Environmental pollution is a serious problem of the modern world that possesses a major threat to public health. Exposure to environmental pollutants during embryonic development is particularly risky. Although many pollutants have been verified as potential toxicants, there are new chemicals in the environment that need assessment. Heart development is an extremely sensitive process, which can be affected by environmentally toxic molecule exposure during embryonic development. Congenital heart defects are the most common life-threatening global health problems, and the etiology is mostly unknown. The zebrafish has emerged as an invaluable model to examine substance toxicity on vertebrate development, particularly on cardiac development. The zebrafish offers numerous advantages for toxicology research not found in other model systems. Many laboratories have used the zebrafish to study the effects of widespread chemicals in the environment on heart development, including pesticides, nanoparticles, and various organic pollutants. Here, we review the uses of the zebrafish in examining effects of exposure to external molecules during embryonic development in causing cardiac defects, including chemicals ubiquitous in the environment and illicit drugs. Known or potential mechanisms of toxicity and how zebrafish research can be used to provide mechanistic understanding of cardiac defects are discussed.

biochemistry & molecular biology,chemistry, multidisciplinary
Animal models of human disease: zebrafish swim into view

Graham J. Lieschke,Peter D. Currie

DOI: https://doi.org/10.1038/nrg2091

IF: 59.581

2007-05-01

Nature Reviews Genetics

Abstract:Key PointsZebrafish have long contributed to biological and medical research, especially as a model for developmental and toxicological studies.Particularly useful attributes of zebrafish include: ex vivo fertilization and embryogenesis; optical transparency of embryos and larvae; rapid embryological development; cheap housing costs; and genetic tractability.Genetic techniques that have been developed for zebrafish make them an attractive vertebrate model for efficient, cost-effective, invertebrate-style forward genetics. Genetic resources include a genome-sequencing project that is nearing completion.Large-scale chemical and insertional mutagenic screens have generated many zebrafish mutants with defects that are analogous to human genetic diseases, at the molecular and cellular-pathological levels.Reverse-genetic techniques such as TILLING (targeting induced local lesions in genomes) allow the recovery of zebrafish with mutant disease-gene alleles, overcoming the lack of a technique for gene targeting by homologous recombination.Transgenic zebrafish disease models with tissue-restricted disease-gene expression and fluorescently marked cell types enable disease mechanisms to be studied in vivo.Zebrafish are proving to be good models of several acquired diseases including cancer, inflammation and infection.Zebrafish are an emerging model for therapeutic drug discovery by 'chemical genetics', whereby chemical libraries are screened to find small molecules that suppress disease-related phenotypes.

genetics & heredity
Zebrafish as an animal model for biomedical research

Tae-Young Choi,Tae-Ik Choi,Yu-Ri Lee,Seong-Kyu Choe,Cheol-Hee Kim

DOI: https://doi.org/10.1038/s12276-021-00571-5

2021-03-01

Abstract:Abstract Zebrafish have several advantages compared to other vertebrate models used in modeling human diseases, particularly for large-scale genetic mutant and therapeutic compound screenings, and other biomedical research applications. With the impactful developments of CRISPR and next-generation sequencing technology, disease modeling in zebrafish is accelerating the understanding of the molecular mechanisms of human genetic diseases. These efforts are fundamental for the future of precision medicine because they provide new diagnostic and therapeutic solutions. This review focuses on zebrafish disease models for biomedical research, mainly in developmental disorders, mental disorders, and metabolic diseases.

biochemistry & molecular biology,medicine, research & experimental
Molecular and Cellular Mechanisms of Vascular Development in Zebrafish

Jean Eberlein,Lukas Herdt,Julian Malchow,Annegret Rittershaus,Stefan Baumeister,Christian SM Helker

DOI: https://doi.org/10.3390/life11101088

2021-10-15

Life

Abstract:The establishment of a functional cardiovascular system is crucial for the development of all vertebrates. Defects in the development of the cardiovascular system lead to cardiovascular diseases, which are among the top 10 causes of death worldwide. However, we are just beginning to understand which signaling pathways guide blood vessel growth in different tissues and organs. The advantages of the model organism zebrafish (Danio rerio) helped to identify novel cellular and molecular mechanisms of vascular growth. In this review we will discuss the current knowledge of vasculogenesis and angiogenesis in the zebrafish embryo. In particular, we describe the molecular mechanisms that contribute to the formation of blood vessels in different vascular beds within the embryo.
Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

G Kari,U Rodeck,A P Dicker

DOI: https://doi.org/10.1038/sj.clpt.6100223

2007-05-09

Abstract:In vivo studies represent an essential step in drug development and currently rely largely on mice, yet limitations of mammalian models motivated the search for complementary vertebrate model systems. This review focuses on zebrafish, Danio rerio, as a facile model system to study human disease and drug responses. Zebrafish are particularly suited for this purpose because they represent a vertebrate species, their genome is sequenced, and a large number of synchronously developing, transparent embryos can be produced. Zebrafish embryos are permeable to drugs and can easily be manipulated using well-established genetic and molecular approaches. Here, we summarize recent work on drug discovery and toxicity in zebrafish embryos. In addition, we provide a synopsis of current efforts to establish disease models in zebrafish focusing on neoplasia. The results of these studies highlight the potential of zebrafish as a viable addition to established animal models by offering medium and, potentially, high throughput capabilities.

pharmacology & pharmacy
Rare Genetic Blood Disease Modeling in Zebrafish

Alberto Rissone,Shawn M. Burgess

DOI: https://doi.org/10.3389/fgene.2018.00348

IF: 3.7

2018-08-31

Frontiers in Genetics

Abstract:Hematopoiesis results in the correct formation of all the different blood cell types. In mammals, it starts from specific hematopoietic stem and precursor cells residing in the bone marrow. Mature blood cells are responsible for supplying oxygen to every cell of the organism and for the protection against pathogens. Therefore, inherited or de novo genetic mutations affecting blood cell formation or the regulation of their activity are responsible for numerous diseases including anemia, immunodeficiency, autoimmunity, hyper- or hypo-inflammation, and cancer. By definition, an animal disease model is an analogous version of a specific clinical condition developed by researchers to gain information about its pathophysiology. Among all the model species used in comparative medicine, mice continue to be the most common and accepted model for biomedical research. However, because of the complexity of human diseases and the intrinsic differences between humans and other species, the use of several models (possibly in distinct species) can often be more helpful and informative than the use of a single model. In recent decades, the zebrafish (Danio rerio) has become increasingly popular among researchers, because it represents an inexpensive alternative compared to mammalian models, such as mice. Numerous advantages make it an excellent animal model to be used in genetic studies and in particular in modeling human blood diseases. Comparing zebrafish hematopoiesis to mammals, it is highly conserved with few, significant differences. In addition, the zebrafish model has a high-quality, complete genomic sequence available that shows a high level of evolutionary conservation with the human genome, empowering genetic and genomic approaches. Moreover, the external fertilization, the high fecundity and the transparency of their embryos facilitate rapid, in vivo analysis of phenotypes. In addition, the ability to manipulate its genome using the last genome editing technologies, provides powerful tools for developing new disease models and understanding the pathophysiology of human disorders. This review provides an overview of the different approaches and techniques that can be used to model genetic diseases in zebrafish, discussing how this animal model has contributed to the understanding of genetic diseases, with a specific focus on the blood disorders.

genetics & heredity
Metabolic insights from zebrafish genetics, physiology, and chemical biology

Amnon Schlegel,Philipp Gut

DOI: https://doi.org/10.1007/s00018-014-1816-8

IF: 8

2015-01-04

Cellular and Molecular Life Sciences

Abstract:Metabolic diseases—atherosclerotic cardiovascular disease, type 2 diabetes mellitus, obesity, and non-alcoholic fatty liver disease––have reached pandemic proportions. Across gene, cell, organ, organism, and social-environmental scales, fundamental discoveries of the derangements that occur in these diseases are required to develop effective new treatments. Here we will review genetic, physiological, pathological and chemical biological discoveries in the emerging zebrafish model for studying metabolism and metabolic diseases. We present a synthesis of recent studies using forward and reverse genetic tools to make new contributions to our understanding of lipid trafficking, diabetes pathogenesis and complications, and to β-cell biology. The technical and physiological advantages and the pharmacological potential of this organism for discovery and validation of metabolic disease targets are stressed by our summary of recent findings. We conclude by arguing that metabolic research using zebrafish will benefit from adoption of conventional blood and tissue metabolite measurements, employment of modern imaging techniques, and development of more rigorous metabolic flux methods.

cell biology,biochemistry & molecular biology
Zebrafish as a Model System for Brugada Syndrome

Leonie Verkerk,Arie O Verkerk,Ronald Wilders

DOI: https://doi.org/10.31083/j.rcm2509313

2024-09-05

Abstract:Brugada syndrome (BrS) is an inheritable cardiac arrhythmogenic disease, associated with an increased risk of sudden cardiac death. It is most common in males around the age of 40 and the prevalence is higher in Asia than in Europe and the United States. The pathophysiology underlying BrS is not completely understood, but several hypotheses have been proposed. So far, the best effective treatment is the implantation of an implantable cardioverter-defibrillator (ICD), but device-related complications are not uncommon. Therefore, there is an urgent need to improve diagnosis and risk stratification and to find new treatment options. To this end, research should further elucidate the genetic basis and pathophysiological mechanisms of BrS. Several experimental models are being used to gain insight into these aspects. The zebrafish (Danio rerio) is a widely used animal model for the study of cardiac arrhythmias, as its cardiac electrophysiology shows interesting similarities to humans. However, zebrafish have only been used in a limited number of studies on BrS, and the potential role of zebrafish in studying the mechanisms of BrS has not been reviewed. Therefore, the present review aims to evaluate zebrafish as an animal model for BrS. We conclude that zebrafish can be considered as a valuable experimental model for BrS research, not only for gene editing technologies, but also for screening potential BrS drugs.
Zebrafish Models in Therapeutic Research of Cardiac Conduction Disease

Rui Gao,Jie Ren

DOI: https://doi.org/10.3389/fcell.2021.731402

IF: 5.5

2021-08-04

Frontiers in Cell and Developmental Biology

Abstract:Malfunction in the cardiac conduction system (CCS) due to congenital anomalies or diseases can cause cardiac conduction disease (CCD), which results in disturbances in cardiac rhythm, leading to syncope and even sudden cardiac death. Insights into development of the CCS components, including pacemaker cardiomyocytes (CMs), atrioventricular node (AVN) and the ventricular conduction system (VCS), can shed light on the pathological and molecular mechanisms underlying CCD, provide approaches for generating human pluripotent stem cell (hPSC)-derived CCS cells, and thus improve therapeutic treatment for such a potentially life-threatening disorder of the heart. However, the cellular and molecular mechanisms controlling CCS development remain elusive. The zebrafish has become a valuable vertebrate model to investigate early development of CCS components because of its unique features such as external fertilization, embryonic optical transparency and the ability to survive even with severe cardiovascular defects during development. In this review, we highlight how the zebrafish has been utilized to dissect the cellular and molecular mechanisms of CCS development, and how the evolutionarily conserved developmental mechanisms discovered in zebrafish could be applied to directing the creation of hPSC-derived CCS cells, therefore providing potential therapeutic strategies that may contribute to better treatment for CCD patients.

cell biology,developmental biology
The Zebrafish As a Model for Human Disease

WT Penberthy,E Shafizadeh,S Lin

DOI: https://doi.org/10.2741/penber

2002-01-01

Frontiers in Bioscience

Abstract:Much of our current understanding of the function of genes modulating the normal process of embryonic development has come from mutant analysis. The availability of thousands of mutant lines in zebrafish that allows for identification of novel genes regulating various aspects of embryogenesis has been instrumental in establishing zebrafish as a robust and reliable genetic system. With the advances in genomic sequencing, the construction of several genetic maps, and cloning of hundreds of ESTs, positional cloning experiments in zebrafish have become more approachable. An increasing number of mutant genes have been cloned. Several zebrafish mutants are representative of known forms of human genetic diseases. The success of morpholino antisense technology in zebrafish potentially opens the door for modeling nearly any inherited developmental defect. This review highlights the strengths and limitations of using the zebrafish as an organism for elucidation of the genetic etiology of human disease. Additionally a survey of current and future zebrafish models of human disease is presented.
Use of Zebrafish Models to Boost Research in Rare Genetic Diseases

Lucie Crouzier,Elodie M. Richard,Jo Sourbron,Lieven Lagae,Tangui Maurice,Benjamin Delprat

DOI: https://doi.org/10.3390/ijms222413356

IF: 5.6

2021-12-12

International Journal of Molecular Sciences

Abstract:Rare genetic diseases are a group of pathologies with often unmet clinical needs. Even if rare by a single genetic disease (from 1/2000 to 1/more than 1,000,000), the total number of patients concerned account for approximatively 400 million peoples worldwide. Finding treatments remains challenging due to the complexity of these diseases, the small number of patients and the challenge in conducting clinical trials. Therefore, innovative preclinical research strategies are required. The zebrafish has emerged as a powerful animal model for investigating rare diseases. Zebrafish combines conserved vertebrate characteristics with high rate of breeding, limited housing requirements and low costs. More than 84% of human genes responsible for diseases present an orthologue, suggesting that the majority of genetic diseases could be modelized in zebrafish. In this review, we emphasize the unique advantages of zebrafish models over other in vivo models, particularly underlining the high throughput phenotypic capacity for therapeutic screening. We briefly introduce how the generation of zebrafish transgenic lines by gene-modulating technologies can be used to model rare genetic diseases. Then, we describe how zebrafish could be phenotyped using state-of-the-art technologies. Two prototypic examples of rare diseases illustrate how zebrafish models could play a critical role in deciphering the underlying mechanisms of rare genetic diseases and their use to identify innovative therapeutic solutions.

An endoscopic approach to metallic foreign bodies of the nose and paranasal sinuses.

Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight

Modeling cardiovascular disease in the zebrafish

Sequential urinary Nτ‐methylhistidine to creatinine ratios in premature infants

Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

Zebrafish Heart Failure Models

Advances in Cardiac Development and Regeneration Using Zebrafish as a Model System for High-Throughput Research

Zebrafish Congenital Heart Disease Models: Opportunities and Challenges

Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity

Insulin Resistance Type A syndrome in a 12-year-old Girl

Zebrafish as a Vertebrate Model System to Evaluate Effects of Environmental Toxicants on Cardiac Development and Function

Animal models of human disease: zebrafish swim into view

Zebrafish as an animal model for biomedical research

Molecular and Cellular Mechanisms of Vascular Development in Zebrafish

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

Rare Genetic Blood Disease Modeling in Zebrafish

Metabolic insights from zebrafish genetics, physiology, and chemical biology

Zebrafish as a Model System for Brugada Syndrome

Zebrafish Models in Therapeutic Research of Cardiac Conduction Disease

The Zebrafish As a Model for Human Disease

Use of Zebrafish Models to Boost Research in Rare Genetic Diseases